GlassScriptPhysician profile
Charles Spieser
NPI 1538929567
$2,257.26
in general payments reported to CMS, 2019-2025
10 companies · $2,011 in 2025
The $2,011 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $246 · 2025: $2,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922 · Education: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.27 |
| Education | $334.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $493.75 | 2025 | Lcp, Va-Lcp, Tfn-Advance |
| Stryker Corporation | $337.50 | 2024-2025 | Triathlon, Mako, Gamma |
| Medical Device Business Services, INC. | $334.99 | 2025 | Actis |
| Legacy Ortho LLC | $322.46 | 2024-2025 | |
| Sanara Medtech INC. | $178.70 | 2025 | Celleraterx |
| Axogen | $169.00 | 2025 | |
| Si-Bone, INC. | $159.93 | 2025 | |
| Heron Therapeutics, INC. | $124.22 | 2024 | Zynrelef |
| Smith+Nephew, INC. | $81.59 | 2024 | Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Orthocell LTD | $55.12 | 2025 | Remplir |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Spieser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.